Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.

What are the lasting impacts of RSV, and how can you prevent your infant from getting the infection? Dr. Stephania Cormier is ...

Pfizer has bolstered the evidence behind its respiratory syncytial virus (RSV) vaccine with a positive trial of the shot used to protect newborns, adding to earlier results in older adults. The ...

Sobi acquired rights to Synagis from AZ in 2019, taking control of a drug that had made more than $1 billion in annual sales at its peak but had started to decline after its patents expired. Last ...

Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...

ROME (AP) — Doctors on Saturday prescribed “absolute rest” for Pope Francis and modified the treatment for his respiratory tract infection, the Vatican said, a day after the 88-year-old pope ...

George Will writes a twice-weekly column on politics and domestic and foreign affairs. He began his column with The Post in 1974, and he received the Pulitzer Prize for commentary in 1977.

Is President Donald Trump on a Collision Course With History? More Than a Century of Data Paints a Clear Picture. Bank of America says growth stocks are in a bubble exceeding the 'dot-com' and ...

ROME (AP) — Pope Francis had breakfast, read the newspapers and followed Mass on television Sunday after a second night sleeping well at the hospital where the 88-year-old pontiff is being ...